Home2026February7Hims Launches Oral Wegovy Knockoff, But The FDA Could Prove To Be A Problem – Investor’s Business Daily Hims Launches Oral Wegovy Knockoff, But The FDA Could Prove To Be A Problem – Investor’s Business Daily February 7, 2026betadmin Hims & Hers Health launched a compounded version of Novo’s oral Wegovy. #stockmarket #breaking
S&P 500 rises as traders await Big Tech earnings: Live updates – CNBC $GOOG $NVDA $MSFT More than 90 S&P 500 companies are slated to report quarterly results this week. #stockmarket #breaking
Dow Jones Futures Rise, Oil Pops, Oracle Dives; SpaceX IPO On Launch Pad – Investor’s Business Daily Here’s what investors should do now. #stockmarket #breaking
China’s July manufacturing activity contracts more than expected — declines for fourth-straight month – CNBC China’s official manufacturing Purchasing Managers’ Index for July was 49.3, missing expectations for 49.7 according to a Reuters poll. #stockmarket…